These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 22893397)

  • 1. The non-obese diabetic (NOD) mouse as a model of human type 1 diabetes.
    Kachapati K; Adams D; Bednar K; Ridgway WM
    Methods Mol Biol; 2012; 933():3-16. PubMed ID: 22893397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in our understanding of the pathophysiology of Type 1 diabetes: lessons from the NOD mouse.
    Jayasimhan A; Mansour KP; Slattery RM
    Clin Sci (Lond); 2014 Jan; 126(1):1-18. PubMed ID: 24020444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of insulin-dependent diabetes mellitus in non-obese diabetic mice by transgenes encoding modified I-A beta-chain or normal I-E alpha-chain.
    Lund T; O'Reilly L; Hutchings P; Kanagawa O; Simpson E; Gravely R; Chandler P; Dyson J; Picard JK; Edwards A
    Nature; 1990 Jun; 345(6277):727-9. PubMed ID: 2163026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and immunological basis of autoimmune diabetes in the NOD mouse.
    Yoshida K; Kikutani H
    Rev Immunogenet; 2000; 2(1):140-6. PubMed ID: 11324686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected functional consequences of xenogeneic transgene expression in beta-cells of NOD mice.
    Leiter EH; Reifsnyder P; Driver J; Kamdar S; Choisy-Rossi C; Serreze DV; Hara M; Chervonsky A
    Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():14-22. PubMed ID: 17919174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of spontaneous autoimmune disease: type 1 diabetes in the nonobese diabetic mouse.
    Giarratana N; Penna G; Adorini L
    Methods Mol Biol; 2007; 380():285-311. PubMed ID: 17876100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humanized NOD/LtSz-scid IL2 receptor common gamma chain knockout mice in diabetes research.
    Shultz LD; Pearson T; King M; Giassi L; Carney L; Gott B; Lyons B; Rossini AA; Greiner DL
    Ann N Y Acad Sci; 2007 Apr; 1103():77-89. PubMed ID: 17332083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical lessening of autoimmune processes in non-obese diabetic mice after infection with the diabetogenic variant of encephalomyocarditis virus.
    Hermitte L; Vialettes B; Naquet P; Atlan C; Payan MJ; Vague P
    Eur J Immunol; 1990 Jun; 20(6):1297-303. PubMed ID: 2164479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comprehensive review of interventions in the NOD mouse and implications for translation.
    Shoda LK; Young DL; Ramanujan S; Whiting CC; Atkinson MA; Bluestone JA; Eisenbarth GS; Mathis D; Rossini AA; Campbell SE; Kahn R; Kreuwel HT
    Immunity; 2005 Aug; 23(2):115-26. PubMed ID: 16111631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. dsAAV8-mediated gene transfer and β-cell expression of IL-4 and β-cell growth factors are capable of reversing early-onset diabetes in NOD mice.
    Gaddy DF; Riedel MJ; Bertera S; Kieffer TJ; Robbins PD
    Gene Ther; 2012 Aug; 19(8):791-9. PubMed ID: 22089495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.
    Bowman MA; Leiter EH; Atkinson MA
    Immunol Today; 1994 Mar; 15(3):115-20. PubMed ID: 8172643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of diabetes in non-obese diabetic I-Ak transgenic mice.
    Slattery RM; Kjer-Nielsen L; Allison J; Charlton B; Mandel TE; Miller JF
    Nature; 1990 Jun; 345(6277):724-6. PubMed ID: 1972779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
    Serreze DV; Marron MP; Dilorenzo TP
    Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetes.
    Pearson JA; Wong FS; Wen L
    J Autoimmun; 2016 Jan; 66():76-88. PubMed ID: 26403950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural history of humoral immunity to glutamic acid decarboxylase in non-obese diabetic (NOD) mice.
    De Aizpurua HJ; French MB; Chosich N; Harrison LC
    J Autoimmun; 1994 Oct; 7(5):643-53. PubMed ID: 7840856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
    Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
    Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of autoimmune insulitis by expression of I-E molecules in NOD mice.
    Nishimoto H; Kikutani H; Yamamura K; Kishimoto T
    Nature; 1987 Jul 30-Aug 5; 328(6129):432-4. PubMed ID: 3302721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of IFN-gamma signaling-deficient NOD mice from diabetes by cyclophosphamide.
    Mori Y; Kato T; Kodaka T; Kanagawa EM; Hori S; Kanagawa O
    Int Immunol; 2008 Sep; 20(9):1231-7. PubMed ID: 18644830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease.
    Bach JF
    C R Acad Sci III; 1992; 314(9 Suppl):45-6. PubMed ID: 1422905
    [No Abstract]   [Full Text] [Related]  

  • 20. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.